Last reviewed · How we verify

Local infiltration of lidocaine — Competitive Intelligence Brief

Local infiltration of lidocaine (Local infiltration of lidocaine) competitive landscape: 6 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Local anesthetic. Area: Anesthesia / Pain Management.

phase 3 Local anesthetic Voltage-gated sodium channels Anesthesia / Pain Management Small molecule Live · refreshed every 30 min

Target snapshot

Local infiltration of lidocaine (Local infiltration of lidocaine) — Kasr El Aini Hospital. Lidocaine blocks sodium channels in nerve cell membranes, preventing depolarization and transmission of pain signals.

Comparator set (6 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

DrugGenericSponsorPhaseClassTargetApproval / PDUFA
Local infiltration of lidocaine TARGET Local infiltration of lidocaine Kasr El Aini Hospital phase 3 Local anesthetic Voltage-gated sodium channels
Lidocaine/Magnesium Lidocaine/Magnesium University of Wisconsin, Madison marketed Local anesthetic combination Voltage-gated sodium channels; NMDA receptor
Buffered Lidocaine Buffered Lidocaine University of California, San Diego marketed Local anesthetic Voltage-gated sodium channels
Lidocaine aerosol 2.4% topical Lidocaine aerosol 2.4% topical Jiangang Song marketed Local anesthetic Voltage-gated sodium channels
Anesthesia (Lidocaine 15%) Anesthesia (Lidocaine 15%) Lumbini Medical College marketed Local anesthetic Voltage-gated sodium channels
bucain + fentanyl bucain + fentanyl University of Debrecen marketed Local anesthetic + opioid analgesic combination Voltage-gated sodium channels (bucain); mu-opioid receptor (fentanyl)
Bupivacaine liposomal injectable suspension Bupivacaine liposomal injectable suspension The University of Texas Health Science Center, Houston marketed Local anesthetic (liposomal formulation) Voltage-gated sodium channels

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Local anesthetic class)

  1. University of California, San Diego · 3 drugs in this class
  2. Durect · 3 drugs in this class
  3. Pacira Pharmaceuticals, Inc · 3 drugs in this class
  4. Wake Forest University Health Sciences · 3 drugs in this class
  5. Medical University of Vienna · 3 drugs in this class
  6. Imperial College London · 2 drugs in this class
  7. Hvidovre University Hospital · 2 drugs in this class
  8. Innocoll · 2 drugs in this class
  9. George Washington University · 2 drugs in this class
  10. Guy's and St Thomas' NHS Foundation Trust · 2 drugs in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Local infiltration of lidocaine — Competitive Intelligence Brief. https://druglandscape.com/ci/local-infiltration-of-lidocaine. Accessed 2026-05-17.

Build your own brief

Pick any drug + add comparators: